A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis

Exclusion Criteria

• •Prior axillary use of botulinum toxin within 2 years of study entry.
• •Prior iontophoresis treatment for axillary hyperhidrosis within 12 weeks of study entry.
• •Prior surgical procedures for hyperhidrosis or surgical procedures in the axillary areas for any reason.
• •Use of anticholinergic treatment, beta-blocker, alpha-adrenergic or other prescription treatment for hyperhidrosis.
• •History of diabetes mellitus, thyroid disease, malignancy, glaucoma, intestinal obstructive or motility disease, obstructive uropathy, myasthenia gravis, prostate hypertrophy, neurological conditions or cardiac abnormalities.
• •Known condition that may cause hyperhidrosis.
• •Use of an investigational drug within 30 days prior to entry into this study.